These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7510030)

  • 21. Antiparasitic nitroimidazoles. 9. Synthesis of some 2-(4-dialkylaminomethylstyryl)-and 2-(4-amidinostyryl)5-nitro-1-vinylimidazoles.
    Ross WJ; Jamieson WB
    J Med Chem; 1975 Apr; 18(4):430-2. PubMed ID: 804556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives in Chagas disease treatment.
    Oliveira GB; Avezum Á; Cordeiro Mattos AJ
    Glob Heart; 2015 Sep; 10(3):189-92. PubMed ID: 26407515
    [No Abstract]   [Full Text] [Related]  

  • 23. Reversibility of muscle and heart lesions in chronic, Trypanosoma cruzi infected mice after late trypanomicidal treatment.
    Segura MA; Molina de Raspi E; Basombrio MA
    Mem Inst Oswaldo Cruz; 1994; 89(2):213-6. PubMed ID: 7885247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of astaxanthin in mice acutely infected with Trypanosoma cruzi.
    Contreras-Ortiz JME; Barbabosa-Pliego A; Oros-Pantoja R; Aparicio-Burgos JE; Zepeda-Escobar JA; Hassan-Moustafa WH; Ochoa-García L; Uxúa Alonso-Fresan M; Tenorio Borroto E; Vázquez-Chagoyán JC
    Parasite; 2017; 24():17. PubMed ID: 28560955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
    Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
    Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease.
    Wong-Baeza C; Nogueda-Torres B; Serna M; Meza-Toledo S; Baeza I; Wong C
    BMC Pharmacol Toxicol; 2015 Apr; 16():10. PubMed ID: 25896924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Allopurinol in the treatment of chronic Chagas' disease].
    Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
    Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
    [No Abstract]   [Full Text] [Related]  

  • 28. Micronucleus formation in bone marrow of mice treated with nifurtimox or benznidazole.
    Gorla NB; Castro JA
    Toxicol Lett; 1985 Jun; 25(3):259-63. PubMed ID: 4012803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types.
    Andrade SG; Magalhães JB; Pontes AL
    Bull World Health Organ; 1985; 63(4):721-6. PubMed ID: 3936634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Isoenzymatic pattern of Trypanosoma cruzi Y strain after specific chemotherapy].
    Silva RC; Santiago CM; Pontes AL; Andrade SG
    Mem Inst Oswaldo Cruz; 1989; 84(1):81-6. PubMed ID: 2108307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease.
    Gallerano RH; Marr JJ; Sosa RR
    Am J Trop Med Hyg; 1990 Aug; 43(2):159-66. PubMed ID: 2117857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chagas' disease: a search for treatment and a question--should the disease be of military concern?
    Kinnamon KE; Poon BT; Scovill JP; Hanson WL; Waits VB
    Mil Med; 1997 Aug; 162(8):527-32. PubMed ID: 9271903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
    Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
    N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A nitroimidazole-thiadiazole derivative with curative action in experimental Trypanosoma cruzi infections.
    Filardi LS; Brener Z
    Ann Trop Med Parasitol; 1982 Jun; 76(3):293-7. PubMed ID: 6812514
    [No Abstract]   [Full Text] [Related]  

  • 36. The in vivo trypanocidal effect of the diterpene 5-epi-icetexone obtained from Salvia gilliesii.
    Lozano E; Strauss M; Spina R; Cifuente D; Tonn C; Rivarola HW; Sosa MA
    Parasitol Int; 2016 Feb; 65(1):23-26. PubMed ID: 26341064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.
    Doyle PS; Zhou YM; Engel JC; McKerrow JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3932-9. PubMed ID: 17698625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cure of short- and long-term experimental Chagas' disease using D0870.
    Urbina JA; Payares G; Molina J; Sanoja C; Liendo A; Lazardi K; Piras MM; Piras R; Perez N; Wincker P; Ryley JF
    Science; 1996 Aug; 273(5277):969-71. PubMed ID: 8688084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Etiological treatment of Chagas' disease].
    Rassi A
    Arq Bras Cardiol; 1982 Apr; 38(4):277-81. PubMed ID: 6820273
    [No Abstract]   [Full Text] [Related]  

  • 40. An update on benznidazole for the treatment of patients with Chagas disease.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.